Januvia Cancer Risk FDA Warning, Lawsuits Filed

Patients should be aware the FDA has issued a warning concerning Januvia™ and increased pancreatic cancer risk and increased thyroid cancer risk. As we previously reported, there may be a link between Januvia and increased cancer risk. Januvia, also known as sitagliptin phosphate, is used to treat Type 2 diabetes. The FDA approved Januvia in March 2006. … Read more